Ilyas Liventsov
Acute Care · Syracuse, NYNPI 1760153985
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,888 of the $3,402 with a category attached, or 84.9%. 5 manufacturers reported payments, led by Abiomed at 47.1% of the total. 2025 is the largest year on record at $1,797, more than ten times the $66 reported in 2022. Among acute care clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $47.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$2K
- AOP Health US, LLC$1K
- Edwards Lifesciences$364
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$159
- Arthrex$106
What the payments were for
- Travel & lodging$51415%
- Food & beverage$2,88885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 40 | $1,602 |
| AOP Health US, LLC | 2 | $1,170 |
| Edwards Lifesciences | 20 | $364 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $159 |
| Arthrex | 1 | $106 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,402 in reported general payments places this provider in the 90th percentile of 980 acute care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,186 |
| Amiodarone Hcl | 11 | $62 |
| ClopidogrelClopidogrel Bisulfate | 18 | $55 |
| Atorvastatin Calcium | 13 | $47 |
| Metoprolol Succinate | 14 | $45 |
| Metoprolol Tartrate | 26 | $38 |
| Lisinopril | 21 | $34 |
| Furosemide | 18 | $11 |
Paid to pharmacies, not to this prescriber.
Other acute care in Syracuse
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Ann HarrisBrooklyn$14K
- Marcel RozarioMedina$10K
- Julie Anne RoldanNew York$10K
- Dana SiscoSuffern$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.